Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina
- PMID: 23869172
- PMCID: PMC3706253
- DOI: 10.2147/CEOR.S40949
Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina
Abstract
Purpose: To measure the impact of a diabetes and cardiovascular risk factors program implemented in a social security institution upon short- and long-term clinical/metabolic outcomes and costs of care.
Methods: Observational longitudinal cohort analysis of clinical/metabolic data and resource use of 300 adult male and female program participants with diabetes before (baseline) and 1 and 3 years after implementation of the program. Data were obtained from clinical records (Qualidiab) and the administration's database.
Results: The implementation of the program in "real world" conditions resulted in an immediate and sustainable improvement of the quality of care provided to people with diabetes incorporated therein. We also recorded a more appropriate oral therapy prescription for hyperglycemia and cardiovascular risk factors (CVRFs), as well as a decrease of events related to chronic complications. This improvement was associated with an increased use of diagnostic and therapeutic resources, particularly those related to pharmacy prescriptions, not specifically used for the control of hyperglycemia and other CVRFs.
Conclusion: The implementation of a diabetes program in real-world conditions results in a significant short- and long-term improvement of the quality of care provided to people with diabetes and other CVRFs, but simultaneously increased the use of resources and the cost of diagnostic and therapeutic practices. Since controlled studies have shown improvement in quality of care without increasing costs, our results suggest the need to include management-control strategies in these programs for appropriate medical and administrative feedback to ensure the simultaneous improvement of clinical outcomes and optimization of the use of resources.
Keywords: chronic diseases; diabetes; management; program evaluation.
Similar articles
-
[Evaluation of the quality of care for diabetic patients in Latin America].Rev Panam Salud Publica. 2001 Nov;10(5):309-17. doi: 10.1590/s1020-49892001001100003. Rev Panam Salud Publica. 2001. PMID: 11774802 Spanish.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Registry of people with diabetes in three Latin American countries: a suitable approach to evaluate the quality of health care provided to people with type 2 diabetes.Int J Clin Pract. 2013 Dec;67(12):1261-6. doi: 10.1111/ijcp.12208. Int J Clin Pract. 2013. PMID: 24246207
-
Impact of a social prescribing intervention in North East England on adults with type 2 diabetes: the SPRING_NE multimethod study.Public Health Res (Southampt). 2023 Mar;11(2):1-185. doi: 10.3310/AQXC8219. Public Health Res (Southampt). 2023. PMID: 37254700
Cited by
-
The costs of diabetes treatment in low- and middle-income countries: a systematic review.BMJ Glob Health. 2019 Feb 27;4(1):e001258. doi: 10.1136/bmjgh-2018-001258. eCollection 2019. BMJ Glob Health. 2019. PMID: 30899566 Free PMC article.
-
Health system costs of providing outpatient care for diabetes in people with TB in the Philippines.IJTLD Open. 2024 Mar 1;1(3):124-129. doi: 10.5588/ijtldopen.23.0554. eCollection 2024 Mar. IJTLD Open. 2024. PMID: 38966408 Free PMC article.
References
-
- Williams R, Van Gaal L, Lucioni C, CODE-2 Advisory Board Assessing the impact of complications on the costs of type II diabetes. Diabetologia. 2002;45(7):S13–S17. - PubMed
-
- Morsanutto A, Berto P, Lopatriello S, et al. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications. 2006;20(3):163–169. - PubMed
-
- Vivian EM. Type 2 diabetes in children and adolescents – the next epidemic? Curr Med Res Opin. 2006;22(2):297–306. - PubMed
-
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853. [No authors listed] - PubMed
- Lancet. 1999;354(9178):602. - PubMed
-
- The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–986. [No authors listed] - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources